Trials / Completed
CompletedNCT04496232
Strategies for Reducing Sperm DNA Fragmentation in ICSI Semen Samples: a Prospective Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Ganin Fertility Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Comparing second ejaculate and physiological ICSI (PICSI) as strategies for improvement of abnormal sperm DNA fragmentation in patients undergoing ICSI.
Detailed description
Sperm DNA fragmentation has shown a negative correlation with embryo quality, fertilization, implantation, clinical pregnancy, and live birth rates. And a positive correlation with the miscarriage rate. Abnormal sperm DNA fragmentation can be improved through the second ejaculate strategy, by limiting the time of sperm presence in the epididymis. PICSI is a robust sperm selection technique that can select individual mature intact sperm DNA. In our study, we will compare PICSI as a valid sperm selection technique to second ejaculate, as a natural cost-free strategy to manage abnormal SDF. In addition to a normal SDF arm as a control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PICSI | Semen processing by density gradient centrifugation followed by sperm selection by PICSI dishes of the first ejaculate |
| OTHER | Second ejaculate | Semen processing by density gradient centrifugation for the second ejaculate |
Timeline
- Start date
- 2020-08-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2020-08-03
- Last updated
- 2022-08-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04496232. Inclusion in this directory is not an endorsement.